Document 3203
 DOCN  M94A3203
 TI    Estimated production loss due to HIV/AIDS mortality in Canada, 1987-91.
 DT    9412
 AU    Hanvelt R; Ruedy N; Hogg RS; Strathdee SA; O'Shaughnessy MV; Montaner
       JS; Schechter MT; BC Centre for Excellence in HIV/AIDS, Vancouver,
       Canada.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):13 (abstract no. 025D). Unique
       Identifier : AIDSLINE ICA10/94369372
 AB    OBJECTIVE: To estimate and compare the impact of HIV/AIDS and other
       select causes of death on future production loss among Canadian men.
       METHODS: Data on all deaths for 1987-1991 attributed to HIV/AIDS and
       other select causes were obtained from Statistics Canada. Future
       production loss was estimated using a human capital approach based on
       potential years of life lost (PYLLs) in men from 25 to 64 years.
       Canadian earnings data for 1990 were obtained from Statistics Canada's
       1991 Survey of Consumer Finances. The present value of future earnings
       in 1990 Canadian dollars was estimated by age and gender assuming 0% and
       2% real growth discounted by 3%, 5% and 7%. RESULTS: The indirect cost
       of future production due to HIV/AIDS mortality in Canada for the period
       1987-91 is estimated to be between $1.4 and $2.6 billion. HIV/AIDS
       attributed deaths account for between 4.4 and 5.1% of the total loss.
       This loss in future earnings is exceeded only by that for ischaemic
       heart disease (15.9% to 17.9%), and cancers of the trachea, bronchus or
       lung (7.1 to 8.2%). Overall, these three categories accounted for 28.0
       to 30.6% of the estimated production loss for men. CONCLUSIONS: Our
       findings demonstrate the dramatic impact of HIV/AIDS mortality on
       current and future wealth production in Canada. The adverse impact of
       HIV/AIDS mortality on future earnings will likely continue to grow
       reflecting the incidence rate of HIV infection. Further, it is likely
       that the relative impact of HIV/AIDS is underestimated due to greater
       under reporting of HIV/AIDS relative to other causes of death. TABULAR
       DATA, SEE ABSTRACT VOLUME.
 DE    Acquired Immunodeficiency Syndrome/*ECONOMICS/MORTALITY  Adult  Canada
       *Economic Value of Life  *Efficiency  Human  HIV
       Infections/*ECONOMICS/MORTALITY  Male  Middle Age  Salaries and Fringe
       Benefits/STATISTICS & NUMER DATA  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).